REQUEST A DEMO
Total
USD $0.00
Search more companies

Gastroenterologia Endoscopia & Reumatologia Sas Ips (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Gastroenterologia Endoscopia & Reumatologia Sas Ips Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Gastroenterologia Endoscopia & Reumatologia Sas Ips is based in Colombia, with the head office in Yopal. It operates in the Ambulatory Health Care Services sector. Gastroenterologia Endoscopia & Reumatologia Sas Ips was incorporated on May 31, 2019. In 2025, the company reported a net sales revenue increase of 5.22%. A negative growth of 7.4% was recorded in its total assets. The net profit margin of Gastroenterologia Endoscopia & Reumatologia Sas Ips decreased by 0.03% in 2025.

Headquarters
Cr 25 11 31
Yopal; Casanare;

Contact Details: Purchase the Gastroenterologia Endoscopia & Reumatologia Sas Ips report to view the information.

Basic Information
Registered Capital:
Purchase the Gastroenterologia Endoscopia & Reumatologia Sas Ips report to view the information.
Financial Auditors:
Purchase the Gastroenterologia Endoscopia & Reumatologia Sas Ips report to view the information.
Incorporation Date:
May 31, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Gastroenterologia Endoscopia & Reumatologia Sas Ips report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
5.22%
Total Operating Revenue
5.22%
Operating Profit
5.99%
EBITDA
5.99%
Net Profit/Loss for the Period
5.01%
Total Assets
-7.4%
Total Equity
22.17%
Operating Profit Margin
0.16%
Net Profit Margin
-0.03%
Return on Equity (ROE)
-2.97%
Quick Ratio
4.93%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?